Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 564 Records) |
Query Trace: Melanoma and BRAF[original query] |
---|
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma. Cancers 2023 9 15 (18): . Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K Eigentler, Janina Remy, Katharina Schober, Markus V Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzm |
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & translational immunology 2023 8 12 (8): e1465. John Wen-Cheng Chang, Chien-Jung Huang, Wen-Kuan Huang, Yu-Chao Wang, Jia-Juan Hsieh, Yao-Yu Chang, Yen-Lin Huang, Chia-Ling Wu, Yeh-Han Wang, Shu-Jen Chen, Kien Thiam Tan, Chiao-Ping Chen, Chiao-En |
Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
A real-world study of adjuvant anti-PD -1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations. Cancer medicine 2023 7 . Wei Sun, Yu Xu, WangJun Yan, ChunMeng Wang, Tu Hu, ZhiGuo Luo, XiaoWei Zhang, Xin Liu, Yong Ch |
Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis. Research square 2023 7 . Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, Berit Gibson, Umang Swami, Alyssa Erickson-Wayman, Debra Jamison, Dan Sageser, Joanne Jeter, Tawnya Bowles, Donald M Cannon, Ben Haaland, Joyce D Schroeder, David Nix, Aaron Atkinson, John Hyngstrom, Jordan McPherson, Aik-Choon Tan, Siwen Hu-Lieskov |
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Frontiers in oncology 2023 7 13 1075823. Ryan C Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M Kirkwood, Greg M Delgoffe, Allison Betof Warner, Yana G Najj |
Distinct senescence mechanisms restrain progression of dysplastic nevi. bioRxiv : the preprint server for biology 2023 7 . Franziska K Lorbeer, Gabrielle Rieser, Aditya Goel, Meng Wang, Areum Oh, Iwei Yeh, Boris C Bastian, Dirk Hockemey |
Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma. Cancers 2023 7 15 (13): . Alyssa Panning, Wolfram Samlowski, Gabriel Allr |
Primary Mucosal Melanoma of the Lip With GNA11 Mutation in a 23-Year-Old Pregnant Woman. Cureus 2023 6 15 (5): e38581. Shivam Khatri, Simon Kashfi, Stephanie Griff |
Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. European journal of cancer (Oxford, England : 1990) 2023 6 . Oliver John Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U Blank, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C J van Akkooi, Caroline Robert, Alexander M M Eggermont, Paul Lorigan, Mario Manda |
Contributions of replicative and translesion DNA polymerases to mutagenic bypass of canonical and atypical UV photoproducts. Nature communications 2023 5 14 (1): 2576. Brittany N Vandenberg, Marian F Laughery, Cameron Cordero, Dalton Plummer, Debra Mitchell, Jordan Kreyenhagen, Fatimah Albaqshi, Alexander J Brown, Piotr A Mieczkowski, John J Wyrick, Steven A Rober |
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors. Journal for immunotherapy of cancer 2023 5 11 (5): . Julia-Christina Stadler, Laura Keller, Christian Mess, Alexander T Bauer, Julian Koett, Glenn Geidel, Isabel Heidrich, Sabine Vidal-Y-Sy, Antje Andreas, Carlotta Stramaglia, Mark Sementsov, Wiebcke Haberstroh, Benjamin Deitert, Inka Lilott Hoehne, Robin Reschke, Thomas Haalck, Klaus Pantel, Christoffer Gebhardt, Stefan W Schneid |
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European journal of cancer (Oxford, England : 1990) 2023 5 188 140-151. Anne Zaremba, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Weichenthal, Patrick Terheyden, Andrea Forschner, Ulrike Leiter, Jens Ulrich, Jochen Utikal, Julia Welzel, Martin Kaatz, Christoffer Gebhardt, Rudolf Herbst, Anca Sindrilaru, Edgar Dippel, Michael Sachse, Frank Meiss, Lucie Heinzerling, Sebastian Haferkamp, Carsten Weishaupt, Harald Löffler, Sophia Kreft, Klaus Griewank, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Lisa Zimm |
Clinicopathologic and genetic characterization of invasive melanoma with BRAF V600K mutation: A study of 16 cases. Journal of cutaneous pathology 2023 5 . Keisuke Goto, Shusuke Yoshikawa, Toshihiro Takai, Kota Tachibana, Keiichiro Honma, Taiki Isei, Yoji Kukita, Takuma Ois |
Role of Single Nucleotide Polymorphism-Related Genes in Tumour Immune Cell Infiltration and Prognosis of Cutaneous Melanoma. BioMed research international 2023 5 2023 3754094. Baihe Wang, Fanxiao Liu, Yuanyuan Li, Nan Ch |
Comparative analysis of adjuvant therapy for stage III BRAF-mut melanoma: A real-world retrospective study from single center in China. Cancer medicine 2023 4 . Zhong Jingqin, Sun Wei, Hu Tu, Wang Chunmeng, Yan Wangjun, Luo Zhiguo, Liu Xin, Xu Yu, Chen Yo |
Analyzing the relationship between the efficacy of first-line immune checkpoint inhibitors and cumulative sun damage in Japanese patients with advanced BRAF wild-type nonacral cutaneous melanoma: A retrospective real-world, multicenter study. Journal of dermatological science 2023 4 . Inozume Takashi, Namikawa Kenjiro, Kato Hiroshi, Yoshikawa Shusuke, Kiniwa Yukiko, Yoshino Koji, Mizuhashi Satoru, Ito Takamichi, Takenouchi Tatsuya, Matsushita Shigeto, Fujisawa Yasuhiro, Matsuzawa Takamitsu, Sugihara Satoru, Asai Jun, Kitagawa Hiroshi, Maekawa Takeo, Isei Taiki, Yasuda Masahito, Yamazaki Naoya, Uhara Hisashi, Nakamura Yasuhi |
Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases. The American Journal of dermatopathology 2023 3 . Mansour Boulos, Vanecek Tomas, Kastnerova Liubov, Nosek Daniel, Kazakov Dmitry V, Donati Miche |
Malignant Melanoma in Older Adults: Different Patient or Different Disease? Cureus 2023 3 15 (2): e34742. Sasson Daniel C, Smetona John T, Parsaei Yassmin, Papageorge Marianna, Ariyan Stephan, Olino Kelly, Clune Jam |
Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
[Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage ?-? melanoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2023 11 45 (11): 973-980. Z G Ren, Y Xu, Z Z Hua, Z Y Mo, L W Wang, G B Shi, W L Liu, W Sun, B Q Zheng, C M Wang, Y J Jin, Y Ch |
Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations. Auris, nasus, larynx 2023 11 . Nayuta Tsushima, Satoshi Kano, Kanako C Hatanaka, Takayoshi Suzuki, Seijiro Hamada, Hiroshi Idogawa, Yuji Nakamaru, Masanobu Suzuki, Yutaka Hatanaka, Akihiro Hom |
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8936-8947. Taylor E Woo, Igor Stukalin, Philip Q Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y Cheung, Daniel Y C Heng, Tina Che |
The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort. Oral oncology 2024 4 152 106807. Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hi |
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations. Cancers 2024 4 16 (7): . Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil, Katy K Tsai, Michael Tetzlaff, Adil Daud, Harish N Vasudev |
Low incidence of BRAF and NRAS mutations in a population with a high incidence of melanoma. Virchows Archiv : an international journal of pathology 2024 1 . Grace Neville, Barbara Marzario, David Shilling, Collette K Hand, Cynthia Heffr |
Incidence of BRAF mutations in cutaneous melanoma: histopathological and molecular analysis of a Ukrainian population. Melanoma management 2024 1 10 (1): MMT64. Oleksandr Dudin, Ozar Mintser, Nazarii Kobyliak, Dmytro Kaminskyi, Roman Shabalkov, Alina Matvieieva, Olga Sukhanova, Antonina Kalmykova, Denys Kozakov, Artem Mashukov, Oksana Sulaie |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: